32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care

Clinical Overview & Pathophysiologic Mechanisms

Palpitations are defined as a conscious, unpleasant awareness of the heartbeat, described variously by patients as pounding, racing, fluttering, skipping, or jumping in the chest or neck. Palpitations account for approximately 16% of all outpatient cardiology referrals and represent the second most common cardiac complaint encountered in primary care following chest pain.

Pathophysiologic Etiologies

Extensive prospective ambulatory cohorts demonstrate that the etiologies of palpitations fall into five primary categories:

1. Cardiac Arrhythmias and Structural Cardiac Disease (~40% to 45%): Premature ventricular contractions (PVCs), premature atrial contractions (PACs), paroxysmal supraventricular tachycardia (PSVT, including atrioventricular nodal reentrant tachycardia [AVNRT] and atrioventricular reentrant tachycardia [AVRT]), atrial fibrillation (AFib), atrial flutter, ventricular tachycardia (VT), sick sinus syndrome, mitral valve prolapse (MVP), and aortic stenosis.
2. Psychiatric and Psychosomatic Conditions (~30% to 35%): Panic disorder, generalized anxiety disorder, major depressive disorder, and somatic symptom disorder. Catecholamine surges amplify physiologic cardiac awareness.
3. Exogenous Substances, Toxins, and Medications (~10% to 15%): Caffeine, alcohol binge consumption ("Holiday Heart Syndrome"), nicotine, prescription or illicit sympathomimetics (pseudoephedrine, phenylephrine, albuterol, amphetamines, cocaine, 3,4-methylenedioxymethamphetamine [MDMA]), theophylline, thyroid hormone overreplacement, and abrupt withdrawal of chronic beta-blockers or clonidine.
4. Non-Cardiac Medical and Endocrine Disorders (~5% to 10%): Hyperthyroidism / thyrotoxicosis, severe anemia (hyperdynamic circulation), fever and systemic sepsis, pregnancy, hypoglycemia, hypoxemia, pheochromocytoma, and severe electrolyte disturbances (hypokalemia, hypomagnesemia, hypocalcemia).
5. Idiopathic / Unexplained (~5% to 10%): No structural, electrical, metabolic, or psychological etiology identified despite exhaustive monitoring.

                    ETIOLOGIC SPECTRUM OF PALPITATIONS

     ┌─────────────────────────────────────────────────────────────┐
     │ Cardiac Arrhythmias & Structural (~43%)                      │
     │  • PVCs / PACs (Ectopy)       • Atrial Fibrillation / Flutter│
     │  • AVNRT / AVRT (PSVT)         • Ventricular Tachycardia (VT)│
     ├─────────────────────────────────────────────────────────────┤
     │ Psychiatric Disorders (~31%)                                │
     │  • Panic Disorder             • Generalized Anxiety Disorder│
     ├─────────────────────────────────────────────────────────────┤
     │ Exogenous & Toxic (~10%)                                    │
     │  • Caffeine / Stimulants      • Alcohol ("Holiday Heart")   │
     │  • Decongestants / Cocaine    • Beta-blocker withdrawal     │
     ├─────────────────────────────────────────────────────────────┤
     │ Systemic Medical (~10%)        │ Idiopathic (~6%)           │
     │  • Hyperthyroidism / Anemia   │  • Benign awareness         │
     │  • Pheochromocytoma / Hypo-K+ │                             │
     └─────────────────────────────────────────────────────────────┘

---

Comprehensive History & Diagnostic Symptom Classification

A meticulous history is the single most powerful diagnostic tool in primary care. Having the patient tap out the rhythm with their fingers on the examination table frequently clarifies the underlying electrophysiologic mechanism faster than verbal descriptions.

Clinical Rhythm Characterization

• "Flip-Flopping", "Thumping", or "Skipped Beats": Typically describes isolated premature atrial contractions (PACs) or premature ventricular contractions (PVCs). The subjective sensation is rarely the ectopic beat itself; rather, it represents the post-extrasystolic compensatory pause followed by augmented ventricular filling, resulting in a hyperdynamic stroke volume on the subsequent normal sinus beat that forcefully impacts the anterior chest wall.
• Rapid, Perfectly Regular Fluttering with Sudden "On/Off" Switching: Strongly indicates paroxysmal supraventricular tachycardia (PSVT), most commonly AVNRT or AVRT. The arrhythmia begins abruptly without a warm-up phase and terminates abruptly (paroxysmal), often spontaneously or following vagal maneuvers (e.g., Valsalva, coughing, splashing cold water on the face).
• Rapid, Irregularly Irregular, Chaotic Racing: Characteristic of atrial fibrillation or, less commonly, atrial flutter with variable atrioventricular conduction or multifocal atrial tachycardia (MAT).
• Pounding Sensation in the Neck ("Frog Sign"): Hallmark of AVNRT. Simultaneous contraction of the atria and ventricles against closed atrioventricular (tricuspid and mitral) valves produces retrograde pressure waves through the superior vena cava, visible and felt as prominent jugular venous cannon a waves in the neck.

Precipitating Triggers and Modulating Factors

• Substances: High caffeine intake (energy drinks), heavy binge alcohol intake ("Holiday Heart Syndrome" precipitating new-onset atrial fibrillation in otherwise healthy young individuals), over-the-counter nasal decongestants containing pseudoephedrine or phenylephrine, dietary weight-loss supplements containing ephedra or bitter orange (synephrine), and herbal stimulants.
• Exertion vs. Rest: Palpitations occurring solely during peak physical exertion suggest exercise-induced ventricular arrhythmias, catecholaminergic polymorphic ventricular tachycardia (CPVT), hypertrophic cardiomyopathy, or ischemia-driven arrhythmias. In contrast, palpitations occurring when lying quietly in bed at night typically represent benign PACs/PVCs or heightened somatic awareness.
• Positional Triggers: Palpitations provoked immediately by bending forward or stooping often indicate AVNRT triggered by transient shifts in intrathoracic pressure and autonomic tone.

---

High-Risk Red Flags Mandating Immediate Triage

Primary care clinicians must rapidly identify red flag symptoms and historical features that signify life-threatening arrhythmogenic risk, warranting direct emergency department transfer or urgent inpatient cardiology admission:

---

Resting 12-Lead Electrocardiogram (ECG) Checklist

A 12-lead resting ECG must be obtained in every patient presenting with palpitations, even if the patient is currently asymptomatic. While the rhythm is usually normal sinus during the clinic visit, the baseline ECG provides essential clues regarding underlying structural heart disease, conduction abnormalities, and inherited channelopathies.

                 12-LEAD ECG EVALUATION CHECKLIST IN PALPITATIONS

      1. RATE & RHYTHM       ──> Sinus brady/tachycardia, PACs, PVCs, AFib/Flutter
      2. PR INTERVAL         ──> Short (<120 ms) with Delta Wave = WPW Syndrome
                                  Prolonged (>200 ms) = First-degree AV Block
      3. QRS DURATION/SHAPE  ──> Wide (>120 ms) = BBB, Ventricular pacing
                                  Epsilon Wave in V1-V3 = ARVC/ARVD
      4. ST-T WAVE MORPHOLOGY──> Coved ST-elevation V1-V2 (≥2 mm) = Brugada Type 1
                                  Asymmetric lateral T-inversions = LVH with Strain
      5. QTc INTERVAL        ──> Prolonged (>450 ms men, >460 ms women, >500 ms critical)

Detailed Electrocardiographic Targets

1. Wolff-Parkinson-White (WPW) Pattern & Pre-Excitation:

   • Criteria: Short PR interval (<120 ms), slurred initial upstroke of the QRS complex (delta wave), widened QRS duration (>120 ms), and secondary ST-T wave discordance.
   • Clinical Significance: Represents an accessory atrioventricular pathway (Bundle of Kent). In the setting of atrial fibrillation, rapid conduction down the accessory pathway bypasses the rate-limiting AV node, allowing ventricular rates to exceed 250-300 bpm, potentially degenerating into ventricular fibrillation and sudden death.
   • Exam Pearl: AV nodal blocking drugs (adenosine, beta-blockers, non-dihydropyridine calcium channel blockers, digoxin) are strictly contraindicated in pre-excited AFib because blocking the AV node shunts 100% of impulses down the accessory pathway, precipitating ventricular fibrillation.

2. Long QT Syndrome (LQTS):

   • Measurement: Bazett-corrected QT interval: QTc = QT / √(RR).
   • Thresholds:
     • Normal: <450 ms in men; <460 ms in women.
     • Borderline: 450 to 470 ms in men; 460 to 480 ms in women.
     • Prolonged: >470 ms in men; >480 ms in women.
     • Severely Prolonged / High Arrhythmic Risk: >500 ms.
   • Pathology: Predisposes to pause-dependent polymorphic ventricular tachycardia (Torsades de Pointes). Can be congenital (KCNQ1, KCNH2, SCN5A mutations) or acquired (hypokalemia, hypomagnesemia, and culprit medications such as macrolides, fluoroquinolones, citalopram, haloperidol, ondansetron, methadone, amiodarone, and sotalol).

3. Brugada Syndrome:

   • Type 1 Morphology: Coved ST-segment elevation ≥2 mm (0.2 mV) in ≥1 right precordial lead (V1, V2), followed by a negative, symmetric T wave.
   • Genetics & Risk: Autosomal dominant loss-of-function mutation in the cardiac sodium channel gene SCN5A. Markedly elevates risk of polymorphic VT and ventricular fibrillation, predominantly during sleep or febrile illness. Unmasked by fever, sodium channel blockers (flecainide, procainamide), and tricyclic antidepressants.

4. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC / ARVD):

   • Findings: Epsilon wave (a distinct low-amplitude terminal notch or deflection at the end of the QRS complex before the ST segment in leads V1 to V3), localized QRS prolongation (>110 ms) in V1-V3, and inverted T waves in V1-V3 in individuals >14 years of age.
   • Pathology: Fibrofatty replacement of the right ventricular myocardium leading to reentrant ventricular arrhythmias and sudden cardiac death in young athletes.

5. Left Ventricular Hypertrophy (LVH) with Repolarization Abnormality (Strain):

   • Sokolow-Lyon Criteria: S in V1 + R in V5 or V6 ≥ 35 mm.
   • Cornell Voltage Criteria: R in aVL + S in V3 > 28 mm (men) or > 20 mm (women).
   • Significance: Asymmetric ST-segment depression and T-wave inversion in lateral leads (I, aVL, V5, V6) reflects subendocardial ischemia from chronic hypertensive remodeling or hypertrophic cardiomyopathy.

---

Ambulatory Electrocardiographic Monitoring Modality Selection

Because palpitations are episodic, the resting 12-lead ECG is frequently normal. The diagnostic yield of ambulatory electrocardiographic monitoring depends entirely on matching the device's recording window to the patient's reported symptom frequency:

          AMBULATORY MONITOR SELECTION BASED ON SYMPTOM FREQUENCY

     Frequency:     DAILY ──────────> WEEKLY ──────────> MONTHLY / RARE
                      │                  │                     │
     Modality:    24-48h Holter     7-14d Patch /       14-30d Event Recorder
                     Monitor        Continuous Loop         or ILR (if syncope)

---

Targeted Laboratory Evaluation & Transthoracic Echocardiogram

Primary Care Laboratory Workup

Routine laboratory testing is indicated in newly presenting palpitations to identify correctable systemic and metabolic drivers:

• Serum Thyroid-Stimulating Hormone (TSH) and Free T4: Unmasks overt or subclinical hyperthyroidism and toxic multinodular goiter.
• Basic Metabolic Panel (BMP) with Serum Magnesium: Detects hypokalemia (<3.5 mEq/L), hypomagnesemia (<1.8 mg/dL), and renal dysfunction that alters drug clearance. Hypokalemia and hypomagnesemia lower the myocardial resting membrane potential, triggering triggered activity and early afterdepolarizations.
• Complete Blood Count (CBC): Evaluates for severe anemia (hemoglobin <8 g/dL), which causes compensatory resting tachycardia and hyperdynamic flow murmurs.
• Urine Toxicology Screen: Recommended when palpitations arise in young adults without prior history, or when clinical signs of sympathetic excess (diaphoresis, mydriasis, hypertension) are present, screening for cocaine, amphetamines, and cannabis.

Indications for Transthoracic Echocardiography (TTE)

Transthoracic echocardiography is not required for every patient with isolated, infrequent, benign ectopy. However, TTE is strongly indicated in the presence of:

1. Any abnormal finding on the 12-lead ECG (pathologic Q waves, bundle branch block, LVH, ischemic ST-T changes).
2. Any pathologic cardiac murmur on physical examination (e.g., systolic ejection murmur radiating to carotids, holosystolic apical murmur of mitral regurgitation, mid-systolic click of MVP).
3. Any episode of exertional presyncope or syncope.
4. Symptoms suggestive of congestive heart failure (peripheral edema, orthopnea, elevated jugular venous pressure).
5. Documented sustained arrhythmia or high ectopy burden (>5% to 10% PVC burden on Holter monitor) to rule out structural cardiomyopathy or tachycardiomyopathy.

---

Outpatient Management, Risk Stratification & Referral Criteria

Low-Risk Ambulatory Management (Benign Ectopy)

When the diagnostic workup (ECG, laboratories, and ambulatory monitoring) confirms benign PACs or isolated low-burden PVCs (<1% of total beats) in the absence of structural heart disease:

• Patient Education and Reassurance: Explain the physiology of the compensatory pause; reassure the patient regarding the benign prognosis.
• Trigger Elimination: Eliminate caffeine, energy drinks, alcohol, tobacco, and sympathomimetic nasal sprays.
• Symptom-Targeted Pharmacotherapy: If palpitations cause disabling distress or functional impairment despite reassurance, initiate a low-dose cardioselective beta-blocker (metoprolol succinate 25 to 50 mg PO daily or atenolol 25 mg PO daily) or a non-dihydropyridine calcium channel blocker (diltiazem extended-release 120 to 180 mg PO daily), provided no conduction disease exists.

Criteria for Emergent Transfer vs. Urgent Cardiology Referral

• Emergency Department Transfer (EMS / 911): Palpitations accompanied by hemodynamic instability (systolic BP <90 mmHg), sustained wide-complex tachycardia on ECG, acute anginal chest pressure, syncope with injury, or acute pulmonary edema.
• Urgent Cardiology / Electrophysiology Referral: Documented WPW pattern on ECG; prolonged QTc (>500 ms); Brugada pattern; ARVC criteria; high PVC burden (>10% to 15% on Holter, which carries long-term risk of PVC-induced dilated cardiomyopathy); paroxysmal atrial fibrillation; or recurrent paroxysmal SVT requiring catheter ablation.